Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.32 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.32 |
| ▸ | KIF11 | P52732 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4313276 | 0.80 | GABRA1 (0.43) | CYP3A4TDP1GABRA1GABRB2 | |
| SCHEMBL9408129 | 0.73 | CYP3A4 (0.40) | CYP3A4TDP1ALDH1A1TP53TAAR1 | |
| SCHEMBL10582680 | 0.71 | ALDH1A1 (0.41) | CYP3A4TDP1ALDH1A1 | |
| SCHEMBL29706645 | 0.69 | CYP3A4 (0.41) | CYP3A4TDP1ALDH1A1TP53GABRA1 | |
| SCHEMBL9408113 | 0.69 | CYP3A4 (0.43) | CYP3A4TDP1ALDH1A1TP53KIF11 | |
| SCHEMBL20108074 | 0.69 | TDP1 (0.50) | CYP3A4TDP1ALDH1A1TP53KIF11 | |
| SCHEMBL10798784 | 0.68 | GABRA1 (0.42) | CYP3A4GABRA1GABRB2 | |
| SCHEMBL2489722 | 0.68 | CYP3A4 (0.37) | CYP3A4TDP1ALDH1A1GABRA1GABRB2 | |
| SCHEMBL31534012 | 0.68 | RPS6KA3 (0.41) | CYP3A4TDP1ALDH1A1TP53TAAR1 | |
| SCHEMBL5373569 | 0.66 | CYP3A4 (0.38) | CYP3A4TDP1ALDH1A1GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1239 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4720199-A1 | SELF-CROSSLINKABLE URETHANE (METH)ACRYLATES | ARKEMA France (FR) | 2026-04-08 | — | — | EP | claimed |
| US-20260042878-A1 | Curable Compositions Comprising At Least One Silane-Modified Polymer | HENKEL AG & CO KGAA (DE) | 2026-02-12 | — | — | US | claimed |
| US-12448476-B2 | Multi(meth)acrylate-functionalized oligomers and methods of preparing and using such oligomers | ARKEMA FRANCE (FR) | 2025-10-21 | — | — | US | claimed |
| US-12343905-B2 | Method for producing cycloolefin resin-decorative molded article | RIMTEC CORPORATION (JP) | 2025-07-01 | — | — | US | claimed |
| CN-114630852-B | Poly (meth) acrylate functionalized oligomers and methods of making and using such oligomers | 阿科玛法国公司 | 2025-02-11 | — | — | CN | claimed |
| CN-119119799-A | Water-based PI matt oil | 苏州市贝特利高分子材料股份有限公司 | 2024-12-13 | — | — | CN | claimed |
| WO-2024245621-A1 | SELF-CROSSLINKABLE URETHANE (METH)ACRYLATES | ARKEMA FRANCE (FR) | 2024-12-05 | — | — | WO | claimed |
| US-12139447-B2 | Method for diisocyanate recovery from distillation residues with bitumen | COVESTRO DEUTSCHLAND AG (DE) | 2024-11-12 | — | — | US | claimed |
| EP-4455178-A1 | CURABLE COMPOSITIONS COMPRISING AT LEAST ONE SILANE-MODIFIED POLYMER | Henkel AG & Co. KGaA (DE) | 2024-10-30 | — | — | EP | claimed |
| EP-3738987-B1 | RADIATION CURABLE POLYMERS | HENKEL AG & CO KGAA (DE) | 2024-07-10 | — | — | EP | claimed |
| EP-2097464-A1 | POLYAMIDE POLYOLS AND POLYURETHANES, METHODS FOR MAKING AND USING, AND PRODUCTS MADE THEREFROM | Arizona Chemical Company (US) | 2009-09-09 | — | — | EP | claimed |
| US-20090053490-A1 | Highly Filled Composite Materials | CLAUSI ROBERT N | 2009-02-26 | — | — | US | claimed |
| EP-1991608-A1 | HIGHLY FILLED COMPOSITE MATERIALS | Clausi, Robert N. (CA) | 2008-11-19 | — | — | EP | claimed |
| US-20080223519-A1 | POLYAMIDE POLYOLS AND POLYURETHANES, METHODS FOR MAKING AND USING, AND PRODUCTS MADE THEREFROM | BANK OF AMERICA, N.A. | 2008-09-18 | — | — | US | claimed |
| WO-2008070762-A1 | POLYAMIDE POLYOLS AND POLYURETHANES, METHODS FOR MAKING AND USING, AND PRODUCTS MADE THEREFROM | ARIZONA CHEMICAL COMPANY (US) | 2008-06-12 | — | — | WO | claimed |
| WO-2007095730-A1 | HIGHLY FILLED COMPOSITE MATERIALS | CLAUSI ROBERT N (CA) | 2007-08-30 | — | — | WO | claimed |
| US-6930196-B2 | Polyurethane hydrogel contact lens | NOVARTIS AG (CH) | 2005-08-16 | — | — | US | claimed |
| US-6520186-B2 | Polyurea, polyurethanes containing silicon compounds | L'OREAL (FR) | 2003-02-18 | — | — | US | claimed |
| US-20020147268-A1 | Reshapable hair styling composition comprising silicon-containing polycondensates | L'OREAL S.A. (FR) | 2002-10-10 | — | — | US | claimed |
| US-20020072562-A1 | Methods and compositions for coating a surface | GEOCEL HOLDINGS CORPORATION | 2002-06-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042878-A1 | Curable Compositions Comprising At Least One Silane-Modified Polymer | CDH1, MECP2, COL14A1 | CYP3A4 4292/4885TDP1 2140/4885ALDH1A1 2682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.